UC San Diego Health has become the first health system in the United States to clinically offer a microRNA-371a-3p blood test for testicular cancer. Developed after more than a decade of research, the test improves diagnosis, treatment planning, and surveillance, while major cancer centers nationwide continue advancing similar biomarker-based testing.
Read More